<strong>Indian</strong> J. Pharm. Pract. 1(2), Jan-Mar, 2009clinical study throws up a gamut <strong>of</strong> questions regarding vaginitis and bacterial vaginosis: a systematicthe specificity and sensitivity to each type <strong>of</strong> infection. review. Obstet Gynecol Surv 2003; 58(5):351-358.Probably sensitivity and cultural studies may throw more 12. Neri A, Rabinerson , Kaplan B. Bacterial vaginosis:light on the subject. Our observations are similar to some drugs versus alternative treatment. Obstet Gynecol(15,16, 17)<strong>of</strong> the trials published earlier. In conclusion, the Surv 1994; 49(12):809-813.13. Available from:URL:www.holisticonline.com/results <strong>of</strong> this study were found to be significant. Thus,Herbal-Med/-Herbs/h143.htm.this study will be extended in larger number <strong>of</strong> patients in14. Loknath S, Shirpa A. Aetiopathological andfuture.therapeutic study on shleshmaja yonivyapada w.s.r.ACKNOWLEDGMENTWe thank the Heads <strong>of</strong> Sri Sai Charitable Dispensary, to infective vaginitis. Suchitr Ayurved 2006; 49-55.15. Renuka K, Nandita K, Vinita S, Vanita R, Urmila T,Bangalore and Shreyas Polyclinic, Bangalore for theirSharadini D. Clinical evaluation <strong>of</strong> PD-959 vaginalhelp in this clinical study. We are thankful to the Principalgel: An open trial. The Antiseptic; 97(11): 400-401.and management <strong>of</strong> Al-Ameen College <strong>of</strong> <strong>Pharmacy</strong> for16. Umadevi K, Swarup Asha. Efficacy <strong>of</strong> PD 959 gel intheir support. We also thank Dr. V. R. Bapat forabnormal vaginal discharge. Asian J. Obstet.suggesting the formulation, free supply <strong>of</strong> the PolyherbalGynecol. <strong>Practice</strong> 1999; 3(1): 68 .capsules (WH1) and for sponsoring this clinical study. 17. Narmada B. Efficacy <strong>of</strong> V-gel in Vaginitis. Obstet &REFERENCESGynecol 1999; 4(2): 111.1. Available from: URL:www.idph.state.il.us/public/hb/hbvaginitis.htm.2. Available from: URL:http://www.pdrhealth.com/patient_education /BHG01ID05.shtml .3. Allsworth JE, Peipert JF. Prevalence <strong>of</strong> bacterialvaginosis: 2001-2004 National Health and NutritionExamination Survey data. Obstet Gynecol 2007;109(1):114-120.4. Mitra SK, Sunitha A, Kumar VV, Pooranesan R,Satyarup S. Multicentric trial on the effect <strong>of</strong> PD-959gel in vaginitis. The <strong>Indian</strong> Practitioner 1997; 50(11):951-954 .5. Friedrich EG. Vaginitis, Am.J.Obstet & Gynaecol1985; 152; 247.6. Tierney LM, McPhee SJ, Papadakis MA. Currentthmedical diagnosis & treatment. 45 ed. 2006; Lange:731-733.7. Bluestein D, Rutledge C, Lumsden L. Predicting theoccurrence <strong>of</strong> antibiotic-induced candidal vaginitis(AICV). Fam. Pract. Res. J 1991; 11:319-326.8. Chapple A, Hassell K, Nicolson M, Cantrill J. Youdon't really feel you can function normally: women'sperceptions and personal management <strong>of</strong> vaginalthrush. J. Reprod. Infant Psychol 2000; 18:309-319.9. Pirotta MV, Garland SM. Genital Candida speciesdetected in samples from women in Melbourne,Australia, before and after treatment with antibiotics.J Clin Microbiol 2006; 44(9):3213-3217.10.Boskey ER. Alternative therapies for bacterialvaginosis: a literature review and acceptabilitysurvey. Altern Ther Health Med 2005 Oct;11(5):38-43.11. Van KK, Assefi N, Marrazzo J, Eckert L. Commoncomplementary and alternative therapies for yeast74
<strong>Indian</strong> J. Pharm. Pract. 1(2), Jan-Mar, 2009<strong>APTI</strong>INTRODUCTIONHome Medication Review is a concept where a likely to be present. A number <strong>of</strong> factors are believed topharmacist has the opportunity to visit a patient in the increase the risk <strong>of</strong> drug related problems in the elderly,familiar surroundings <strong>of</strong> the latter's home and questions including suboptimal prescribing (e.g. overuse <strong>of</strong>that no one has been able to confidently answer can be medications or polypharmacy, inappropriate use, andanswered. Medication review takes the pharmacist out <strong>of</strong> under use), medication errors (both by dispensing andthe shop into the community. Home medication review is administration problems) and patient medication, nonanexciting opportunity for <strong>Indian</strong> pharmacist to adherence (both intentional and unintentional) [2].contribute further to the health care <strong>of</strong> their communities. A number <strong>of</strong> studies have investigated medications andThe human body is in a state <strong>of</strong> change as the years go by. [3,4]medication-related risk factors in patients' homesThere is a progressive functional decline in many organ however,the medication-related problems found in thosesystems with advancing age. Age-associated physiologic studies werenot linked to patients health outcomes.changes may cause reduction in functional reserve Other studies have sought to investigate the relationshipscapacity (i.e. the ability to respond physiologic between a limited number <strong>of</strong> medication-related riskchallenges or stresses). The cardiovascular, factors that might be identified by a home visit andmusculoskeletal and central nervous system appears to adverse health outcomes. Hospital admission secondarybe most affected. The elderly have multiple and <strong>of</strong>ten to adverse drug reactions was found to be related to thechronic diseases. It is not surprising therefore that they use <strong>of</strong> two or more pharmacies, while drug side effects[1].are the major consumers <strong>of</strong> drugs There has been a were reported as the reason for non-adherence in 35% <strong>of</strong>steady increase in the number <strong>of</strong> elderly people, defined patients whose admission was related to non-adherence [5].as those over 65 years <strong>of</strong> age. Several conditions are Non-adherence also precipitated about 5% <strong>of</strong> hospitalreadmissions in geriatric patients previously dischargedon three or more drugs prescribed for chronic<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>Practice</strong>Received on 03/02/2009 Modified on 13/02/2009Accepted on 17/03/2009 © <strong>APTI</strong> All rights reserved<strong>ijopp</strong>Prevalence <strong>of</strong> Diseases and Observation <strong>of</strong> Drug Utilization Patternin Geriatric Patients: A Home Medication Review1 2 3Pandey Awanish ,Tripathi Poonam ,Pandey Rishabh DevM.Pharm, Institute <strong>of</strong> technology and Management, GorakhpurAddress for correspondence: awanishpandey@rediffmail.comAbstractGeriatric patients may have medication-related risk factors only identified by home visits, but the extent to whichthoserisk factors are associated with poor health outcomes remainsunclear. To observe the drug utilization patternand prevalence <strong>of</strong> chronic diseases in elderly by visiting them in their community. A door-to-door survey wasconducted in an area <strong>of</strong> 2 sq. km surrounding Shri Mahant Indiresh Hospital <strong>of</strong> Dehradun, to identify geriatricresidents, diseases prevalent in them and prescription pattern. The study was primarily targeted at the elderlybecause, as a group they take more drugs than their younger counterparts and are known to be at risk <strong>of</strong> the sideeffects <strong>of</strong> many <strong>of</strong> the drugs they consume. The result <strong>of</strong> this study showed that 34 % geriatric patients were sufferingfrom cardiac disorder while 22% from diabetes and 18% from osteoarthritis among elderly population. 40%patients were non-compliant due to poor economic status, difficulty in swallowing <strong>of</strong> the prescribed dosage forms,and disturbing side effects. Self-medication (38%) was a prevalent phenomenon among the elderly. The studyconclude that cardiac disorders, diabetes and rheumatism were the most prevalent diseases and self-medicationwas the prevalent phenomenon responsible for the adverse drug reactions in geriatric patients. The study suggeststhat elderly patient education through home medication review can significantly improve patient knowledge andcompliance with medication.Keywords: Home medication review, Noncompliance, Selfmedication, Geriatrics, Polypharmacy[6].conditions Similarly, poor adherence was associated75
- Page 1:
Indian Journal of Pharmacy Practice
- Page 4 and 5:
Indian Journal of Pharmacy Practice
- Page 7 and 8:
APTIIndian J. Pharm. Pract. 1(2), J
- Page 10 and 11:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 12 and 13:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 14 and 15:
APTIijoppGenesis, Development and P
- Page 16 and 17:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 19 and 20:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 21 and 22:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 23 and 24:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 25 and 26:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 27 and 28:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 29 and 30: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 31 and 32: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 33 and 34: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 35 and 36: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 37 and 38: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 39 and 40: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 41 and 42: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 43 and 44: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 45 and 46: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 47 and 48: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 49 and 50: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 51 and 52: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 53 and 54: pivotal to the rational use of medi
- Page 55 and 56: .leadership” (Cohen, 1984). A stu
- Page 57 and 58: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 59 and 60: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 61 and 62: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 63 and 64: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 65 and 66: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 67 and 68: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 69 and 70: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 71 and 72: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 73 and 74: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 75 and 76: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 77 and 78: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 79: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 83 and 84: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 85 and 86: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 87 and 88: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 89 and 90: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 91 and 92: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 93 and 94: Indian J. Pharm. Pract. 1(2), Jan-M